David Aviezer
Président chez Metabomed Ltd.
Profil
David Aviezer is currently the Chairman of Metabomed Ltd.
He was previously the President & Chief Executive Officer of Orthodontix, Inc. from 2006 to 2007 and the President, Chief Executive Officer & Director of Protalix Biotherapeutics, Inc. from 2010 to 2014.
Dr. Aviezer has an undergraduate degree and an MBA from Bar-Ilan University and a graduate degree and doctorate from Weizmann Institute of Science.
Postes actifs de David Aviezer
| Sociétés | Poste | Début |
|---|---|---|
Metabomed Ltd.
 Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Président | - |
Anciens postes connus de David Aviezer
| Sociétés | Poste | Fin |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Directeur Général | 02/11/2014 |
| Orthodontix, Inc. | President | 01/03/2007 |
Formation de David Aviezer
| Weizmann Institute of Science | Doctorate Degree |
| Bar-Ilan University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Orthodontix, Inc. | Finance |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Health Technology |
